{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T01:14:16Z","timestamp":1783300456173,"version":"3.54.6"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the State Key Laboratory of Drug Regulatory Science","award":["2024SKLDRS0205"],"award-info":[{"award-number":["2024SKLDRS0205"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08251-6","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T10:34:54Z","timestamp":1778495694000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["An intramuscular prime-intranasal boost strategy for mRNA-LNP vaccine induces mucosal immune response against SARS-CoV-2 in murine model"],"prefix":"10.1186","volume":"24","author":[{"given":"Jialu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanxing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanxuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junying","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingchen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenglun","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunying","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"8251_CR1","doi-asserted-by":"crossref","unstructured":"Barker KA, Etesami NS, Shenoy AT, Arafa EI, Lyon de Ana C, Smith NM, et al. Lung-resident memory B cells protect against bacterial pneumonia. J Clin Invest. 2021;131(11).","DOI":"10.1172\/JCI141810"},{"issue":"4 Suppl","key":"8251_CR2","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1038\/nm1213","volume":"11","author":"J Holmgren","year":"2005","unstructured":"Holmgren J, Czerkinsky C. Mucosal immunity and vaccines. Nat Med. 2005;11(4 Suppl):S45\u201353.","journal-title":"Nat Med"},{"issue":"7","key":"8251_CR3","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1073\/pnas.1115369109","volume":"109","author":"T Onodera","year":"2012","unstructured":"Onodera T, Takahashi Y, Yokoi Y, Ato M, Kodama Y, Hachimura S, et al. Memory B cells in the lung participate in protective humoral immune responses to pulmonary influenza virus reinfection. Proc Natl Acad Sci U S A. 2012;109(7):2485\u201390.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"8251_CR4","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1084\/jem.20181365","volume":"216","author":"LK Beura","year":"2019","unstructured":"Beura LK, Fares-Frederickson NJ, Steinert EM, Scott MC, Thompson EA, Fraser KA, et al. CD4(+) resident memory T cells dominate immunosurveillance and orchestrate local recall responses. J Exp Med. 2019;216(5):1214\u201329.","journal-title":"J Exp Med"},{"issue":"1","key":"8251_CR5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41392-022-00997-x","volume":"7","author":"Y Fan","year":"2022","unstructured":"Fan Y, Li X, Zhang L, Wan S, Zhang L, Zhou F. SARS-CoV-2 Omicron variant: recent progress and future perspectives. Signal Transduct Target Ther. 2022;7(1):141.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"8251_CR6","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.1038\/s41467-022-31200-y","volume":"13","author":"F Armando","year":"2022","unstructured":"Armando F, Beythien G, Kaiser FK, Allnoch L, Heydemann L, Rosiak M, et al. SARS-CoV-2 Omicron variant causes mild pathology in the upper and lower respiratory tract of hamsters. Nat Commun. 2022;13(1):3519.","journal-title":"Nat Commun"},{"key":"8251_CR7","doi-asserted-by":"crossref","unstructured":"van Doremalen N, Purushotham JN, Schulz JE, Holbrook MG, Bushmaker T, Carmody A, et al. Intranasal ChAdOx1 nCoV-19\/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models. Sci Transl Med. 2021; 13(607).","DOI":"10.1126\/scitranslmed.abh0755"},{"key":"8251_CR8","doi-asserted-by":"crossref","unstructured":"Sharun K, Dhama K. India\u2019s role in COVID-19 vaccine diplomacy. J Travel Med. 2021; 28(7).","DOI":"10.1093\/jtm\/taab064"},{"key":"8251_CR9","doi-asserted-by":"crossref","unstructured":"Wang Y, Yang C, Song Y, Coleman JR, Stawowczyk M, Tafrova J, et al. Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy. Proc Natl Acad Sci USA. 2021;118(29).","DOI":"10.1073\/pnas.2102775118"},{"issue":"3","key":"8251_CR10","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00296-021-04792-9","volume":"41","author":"T Velikova","year":"2021","unstructured":"Velikova T, Georgiev T. SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis. Rheumatol Int. 2021;41(3):509\u201318.","journal-title":"Rheumatol Int"},{"key":"8251_CR11","doi-asserted-by":"crossref","unstructured":"An X, Martinez-Paniagua M, Rezvan A, Sefat SR, Fathi M, Singh S, et al. Single-dose intranasal vaccination elicits systemic and mucosal immunity against SARS-CoV-2. iScience. 2021;24(9):103037.","DOI":"10.1016\/j.isci.2021.103037"},{"issue":"18","key":"8251_CR12","doi-asserted-by":"publisher","first-page":"e124","DOI":"10.3346\/jkms.2021.36.e124","volume":"36","author":"Z Jia","year":"2021","unstructured":"Jia Z, Gong W. Will Mutations in the Spike Protein of SARS-CoV-2 Lead to the Failure of COVID-19 Vaccines? J Korean Med Sci. 2021;36(18):e124.","journal-title":"J Korean Med Sci"},{"key":"8251_CR13","doi-asserted-by":"publisher","first-page":"571248","DOI":"10.3389\/fimmu.2020.571248","volume":"11","author":"Q He","year":"2020","unstructured":"He Q, Jiang L, Cao K, Zhang L, Xie X, Zhang S, et al. A Systemic Prime-Intrarectal Pull Strategy Raises Rectum-Resident CD8\u2009+\u2009T Cells for Effective Protection in a Murine Model of LM-OVA Infection. Front Immunol. 2020;11:571248.","journal-title":"Front Immunol"},{"issue":"6622","key":"8251_CR14","doi-asserted-by":"publisher","first-page":"eabo2523","DOI":"10.1126\/science.abo2523","volume":"378","author":"T Mao","year":"2022","unstructured":"Mao T, Israelow B, Pe\u00f1a-Hern\u00e1ndez MA, Suberi A, Zhou L, Luyten S, et al. Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses. Science. 2022;378(6622):eabo2523.","journal-title":"Science"},{"issue":"1","key":"8251_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41392-022-00926-y","volume":"7","author":"Q He","year":"2022","unstructured":"He Q, Mao Q, Peng X, He Z, Lu S, Zhang J, et al. Immunogenicity and protective efficacy of a recombinant protein subunit vaccine and an inactivated vaccine against SARS-CoV-2 variants in non-human primates. Signal Transduct Target Ther. 2022;7(1):69.","journal-title":"Signal Transduct Target Ther"},{"issue":"7424","key":"8251_CR16","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nature11522","volume":"491","author":"H Shin","year":"2012","unstructured":"Shin H, Iwasaki A. A vaccine strategy that protects against genital herpes by establishing local memory T cells. Nature. 2012;491(7424):463\u20137.","journal-title":"Nature"},{"issue":"4","key":"8251_CR17","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.4049\/jimmunol.1800219","volume":"202","author":"N \u00c7uburu","year":"2019","unstructured":"\u00c7uburu N, Kim R, Guittard GC, Thompson CD, Day PM, Hamm DE, et al. A Prime-Pull-Amplify Vaccination Strategy To Maximize Induction of Circulating and Genital-Resident Intraepithelial CD8(+) Memory T Cells. J Immunol. 2019;202(4):1250\u201364.","journal-title":"J Immunol"},{"key":"8251_CR18","doi-asserted-by":"publisher","first-page":"1063679","DOI":"10.3389\/fimmu.2022.1063679","volume":"13","author":"R Sunagar","year":"2022","unstructured":"Sunagar R, Prasad SD, Ella R, Vadrevu KM. Preclinical evaluation of safety and immunogenicity of a primary series intranasal COVID-19 vaccine candidate (BBV154) and humoral immunogenicity evaluation of a heterologous prime-boost strategy with COVAXIN (BBV152). Front Immunol. 2022;13:1063679.","journal-title":"Front Immunol"},{"issue":"4","key":"8251_CR19","doi-asserted-by":"publisher","first-page":"e0198924","DOI":"10.1128\/jvi.01989-24","volume":"99","author":"AC Beavis","year":"2025","unstructured":"Beavis AC, Li Z, Briggs K, Gingerich MC, Wrobel ER, Najera M, et al. Efficacy of parainfluenza virus 5 (PIV5)-vectored intranasal COVID-19 vaccine as a single dose primer and booster against SARS-CoV-2 variants. J Virol. 2025;99(4):e0198924.","journal-title":"J Virol"},{"key":"8251_CR20","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1146\/annurev-immunol-042617-053214","volume":"37","author":"D Masopust","year":"2019","unstructured":"Masopust D, Soerens AG, Tissue-Resident T. Cells and Other Resident Leukocytes. Annu Rev Immunol. 2019;37:521\u201346.","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"8251_CR21","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.immuni.2021.03.005","volume":"54","author":"PA Szabo","year":"2021","unstructured":"Szabo PA, Dogra P, Gray JI, Wells SB, Connors TJ, Weisberg SP, et al. Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19. Immunity. 2021;54(4):797\u2013e814796.","journal-title":"Immunity"},{"issue":"1","key":"8251_CR22","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.immuni.2006.04.017","volume":"25","author":"RS Allan","year":"2006","unstructured":"Allan RS, Waithman J, Bedoui S, Jones CM, Villadangos JA, Zhan Y, et al. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity. 2006;25(1):153\u201362.","journal-title":"Immunity"},{"issue":"10","key":"8251_CR23","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/nri2836","volume":"10","author":"A Iwasaki","year":"2010","unstructured":"Iwasaki A. Antiviral immune responses in the genital tract: clues for vaccines. Nat Rev Immunol. 2010;10(10):699\u2013711.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"8251_CR24","doi-asserted-by":"publisher","first-page":"e604","DOI":"10.1002\/iid3.604","volume":"10","author":"S Kar","year":"2022","unstructured":"Kar S, Devnath P, Emran TB, Tallei TE, Mitra S, Dhama K. Oral and intranasal vaccines against SARS-CoV-2: Current progress, prospects, advantages, and challenges. Immun Inflamm Dis. 2022;10(4):e604.","journal-title":"Immun Inflamm Dis"},{"issue":"11","key":"8251_CR25","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/s41573-024-01042-y","volume":"23","author":"N Pardi","year":"2024","unstructured":"Pardi N, Krammer F. mRNA vaccines for infectious diseases - advances, challenges and opportunities. Nat Rev Drug Discov. 2024;23(11):838\u201361.","journal-title":"Nat Rev Drug Discov"},{"key":"8251_CR26","doi-asserted-by":"crossref","unstructured":"Zhuang X, Qi Y, Wang M, Yu N, Nan F, Zhang H et al. mRNA Vaccines Encoding the HA Protein of Influenza A H1N1 Virus Delivered by Cationic Lipid Nanoparticles Induce Protective Immune Responses in Mice. Vaccines (Basel) 2020; 8(1).","DOI":"10.3390\/vaccines8010123"},{"key":"8251_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jconrel.2016.02.043","volume":"228","author":"M Li","year":"2016","unstructured":"Li M, Zhao M, Fu Y, Li Y, Gong T, Zhang Z, et al. Enhanced intranasal delivery of mRNA vaccine by overcoming the nasal epithelial barrier via intra- and paracellular pathways. J Control Release. 2016;228:9\u201319.","journal-title":"J Control Release"},{"issue":"4","key":"8251_CR28","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41578-022-00529-7","volume":"8","author":"SA Dilliard","year":"2023","unstructured":"Dilliard SA, Siegwart DJ. Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs. Nat Rev Mater. 2023;8(4):282\u2013300.","journal-title":"Nat Rev Mater"},{"issue":"4","key":"8251_CR29","doi-asserted-by":"publisher","first-page":"e188","DOI":"10.1002\/mco2.188","volume":"3","author":"J Zhang","year":"2022","unstructured":"Zhang J, He Q, Yan X, Liu J, Bai Y, An C, et al. Mixed formulation of mRNA and protein-based COVID-19 vaccines triggered superior neutralizing antibody responses. MedComm (2020). 2022;3(4):e188.","journal-title":"MedComm (2020)"},{"issue":"1","key":"8251_CR30","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1080\/22221751.2021.1957401","volume":"10","author":"J Zhang","year":"2021","unstructured":"Zhang J, He Q, An C, Mao Q, Gao F, Bian L, et al. Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine. Emerg Microbes Infect. 2021;10(1):1598\u2013608.","journal-title":"Emerg Microbes Infect"},{"issue":"5","key":"8251_CR31","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1097\/01.shk.0000142249.08135.e9","volume":"22","author":"H Watanabe","year":"2004","unstructured":"Watanabe H, Numata K, Ito T, Takagi K, Matsukawa A. Innate immune response in Th1- and Th2-dominant mouse strains. Shock. 2004;22(5):460\u20136.","journal-title":"Shock"},{"issue":"14","key":"8251_CR32","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.micinf.2004.07.010","volume":"6","author":"N Gui\u00f1az\u00fa","year":"2004","unstructured":"Gui\u00f1az\u00fa N, Pellegrini A, Giordanengo L, Aoki MP, Rivarola HW, Cano R, et al. Immune response to a major Trypanosoma cruzi antigen, cruzipain, is differentially modulated in C57BL\/6 and BALB\/c mice. Microbes Infect. 2004;6(14):1250\u20138.","journal-title":"Microbes Infect"},{"issue":"2","key":"8251_CR33","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1128\/JVI.02012-06","volume":"81","author":"PB McCray Jr","year":"2007","unstructured":"McCray PB Jr., Pewe L, Wohlford-Lenane C, Hickey M, Manzel L, Shi L, et al. Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus. J Virol. 2007;81(2):813\u201321.","journal-title":"J Virol"},{"issue":"5","key":"8251_CR34","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1473-3099(20)30985-3","volume":"21","author":"M Marks","year":"2021","unstructured":"Marks M, Millat-Martinez P, Ouchi D, Roberts CH, Alemany A, Corbacho-Monn\u00e9 M, et al. Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study. Lancet Infect Dis. 2021;21(5):629\u201336.","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"8251_CR35","doi-asserted-by":"publisher","first-page":"102547","DOI":"10.1016\/j.omtn.2025.102547","volume":"36","author":"MN Vu","year":"2025","unstructured":"Vu MN, Pilapitiya D, Kelly A, Koutsakos M, Kent SJ, Juno JA, et al. Deconvolution of cargo delivery and immunogenicity following intranasal delivery of mRNA lipid nanoparticle vaccines. Mol Ther Nucleic Acids. 2025;36(2):102547.","journal-title":"Mol Ther Nucleic Acids"},{"key":"8251_CR36","doi-asserted-by":"publisher","first-page":"101813","DOI":"10.1016\/j.mtbio.2025.101813","volume":"32","author":"Y Lu","year":"2025","unstructured":"Lu Y, Yang Y, Yi J, Hong X, Lou J, Li M, et al. Design, optimization, and evaluation of lyophilized lipid nanoparticles for mRNA-based pulmonary mucosal vaccination. Mater Today Bio. 2025;32:101813.","journal-title":"Mater Today Bio"},{"issue":"78","key":"8251_CR37","doi-asserted-by":"publisher","first-page":"eadd3075","DOI":"10.1126\/sciimmunol.add3075","volume":"7","author":"M K\u00fcnzli","year":"2022","unstructured":"K\u00fcnzli M, O\u2019Flanagan SD, LaRue M, Talukder P, Dileepan T, Stolley JM, et al. Route of self-amplifying mRNA vaccination modulates the establishment of pulmonary resident memory CD8 and CD4 T cells. Sci Immunol. 2022;7(78):eadd3075.","journal-title":"Sci Immunol"},{"issue":"9","key":"8251_CR38","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1038\/s41551-021-00786-x","volume":"5","author":"MP Lokugamage","year":"2021","unstructured":"Lokugamage MP, Vanover D, Beyersdorf J, Hatit MZC, Rotolo L, Echeverri ES, et al. Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs. Nat Biomed Eng. 2021;5(9):1059\u201368.","journal-title":"Nat Biomed Eng"},{"issue":"4","key":"8251_CR39","doi-asserted-by":"publisher","first-page":"e29625","DOI":"10.1002\/jmv.29625","volume":"96","author":"G Song","year":"2024","unstructured":"Song G, Li R, Cheng MQ. Safety, immunogenicity, and protective effective of inhaled COVID-19 vaccines: A systematic review and meta-analysis. J Med Virol. 2024;96(4):e29625.","journal-title":"J Med Virol"},{"issue":"3","key":"8251_CR40","doi-asserted-by":"publisher","first-page":"e70093","DOI":"10.1111\/irv.70093","volume":"19","author":"S Yahyaei","year":"2025","unstructured":"Yahyaei S, Abdoli A, Jamali A, Teimoori A, Arefian E, Eftekhari Z, et al. Targeting Respiratory Viruses: The Efficacy of Intranasal mRNA Vaccination in Generating Protective Mucosal and Systemic Immunity Against Influenza A (H1N1). Influenza Other Respir Viruses. 2025;19(3):e70093.","journal-title":"Influenza Other Respir Viruses"},{"key":"8251_CR41","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.jconrel.2021.12.008","volume":"342","author":"G Anderluzzi","year":"2022","unstructured":"Anderluzzi G, Lou G, Woods S, Schmidt ST, Gallorini S, Brazzoli M, et al. The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency. J Control Release. 2022;342:388\u201399.","journal-title":"J Control Release"},{"issue":"38","key":"8251_CR42","doi-asserted-by":"publisher","first-page":"eadh1655","DOI":"10.1126\/sciadv.adh1655","volume":"9","author":"G Baldeon Vaca","year":"2023","unstructured":"Baldeon Vaca G, Meyer M, Cadete A, Hsiao CJ, Golding A, Jeon A, et al. Intranasal mRNA-LNP vaccination protects hamsters from SARS-CoV-2 infection. Sci Adv. 2023;9(38):eadh1655.","journal-title":"Sci Adv"},{"issue":"20","key":"8251_CR43","doi-asserted-by":"publisher","first-page":"5225","DOI":"10.1073\/pnas.1620194114","volume":"114","author":"A Pizzolla","year":"2017","unstructured":"Pizzolla A, Wang Z, Groom JR, Kedzierska K, Brooks AG, Reading PC, et al. Nasal-associated lymphoid tissues (NALTs) support the recall but not priming of influenza virus-specific cytotoxic T cells. Proc Natl Acad Sci U S A. 2017;114(20):5225\u201330.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8251_CR44","doi-asserted-by":"crossref","unstructured":"Horns F, Vollmers C, Croote D, Mackey SF, Swan GE, Dekker CL, et al. Lineage tracing of human B cells reveals the in vivo landscape of human antibody class switching. Elife 2016; 5.","DOI":"10.7554\/eLife.23066"},{"issue":"5","key":"8251_CR45","doi-asserted-by":"publisher","first-page":"e0226322","DOI":"10.1128\/spectrum.02263-22","volume":"10","author":"Y Bai","year":"2022","unstructured":"Bai Y, He Q, Yang J, Lu S, Mao Q, Gao F, et al. B.1.351 SARS-CoV-2 Variant exhibits higher virulence but less viral shedding than that of the ancestral strain in young nonhuman primates. Microbiol Spectr. 2022;10(5):e0226322.","journal-title":"Microbiol Spectr"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08251-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08251-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08251-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:16:21Z","timestamp":1783296981000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08251-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8251"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08251-6","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal immunization procedures were approved by the Institutional Animal Care and Use Committee of the National Institutes for Food and Drug Control, China (Approval No. 2022-B016). Viral challenge protocols were approved by the Animal Laboratory Center of Wuhan Institute of Biological Products Co., Ltd. (Ethical Approval No. WIBP-AII442021005). All animal experiments performed according to the guidelines for the ethical review of laboratory animal welfare People\u2019s Republic of China National Standard GB\/T 35892\u2009\u2212\u20092018.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors have consented to the publication of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"853"}}